The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...
The US Food and Drug Administration on Wednesday issued a draft guidance to help companies reduce animal studies of ...
Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results